Molecular Docking Study Characterization of Rare Flavonoids at the Nac-Binding Site of the First Bromodomain of BRD4 (BRD4 BD1)

<div>Known inhibitors. <svg height="12.0395pt" id="M1" style="vertical-align:-2.3616pt" version="1.1" viewbox="-0.0498162 -9.6779 16.3096 12.0395" width="16.3096pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M300 -147C201 -63 143 98 143 270S200 602 300 686L282 710C136 610 70 450 70 271V270C70 89 136 -72 282 -170L300 -147Z" id="g113-41"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,4.688,0)"><path d="M409 0V34C329 39 322 56 322 125V635C234 611 160 593 94 583V554L145 551C186 547 190 541 190 488V125C190 54 181 39 102 34V0H409Z" id="g13-47"></path><glyph.data ascent="1024" descent="-360" horiz-adv-x="500" vert-adv-y="500"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,11.462,0)"><path d="M275 270C275 450 212 609 64 710L45 686C145 604 203 442 203 270S147 -63 45 -147L64 -170C213 -68 275 89 275 270Z" id="g113-42"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g></svg> Midazolam, <svg height="12.0395pt" id="M2" style="vertical-align:-2.3616pt" version="1.1" viewbox="-0.0498162 -9.6779 16.3096 12.0395" width="16.3096pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M300 -147C201 -63 143 98 143 270S200 602 300 686L282 710C136 610 70 450 70 271V270C70 89 136 -72 282 -170L300 -147Z" id="g113-41"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,4.688,0)"><path d="M440 175C403 110 395 108 335 108H173L293 222C391 316 432 379 432 457C432 568 349 635 250 635C187 635 137 610 100 573L36 479L65 456C97 502 138 544 199 544C268 544 303 495 303 425C303 349 264 274 194 191C145 133 86 78 33 26V0H434C445 42 457 105 473 164L440 175Z" id="g13-48"></path><glyph.data ascent="1024" descent="-360" horiz-adv-x="500" vert-adv-y="500"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,11.462,0)"><path d="M275 270C275 450 212 609 64 710L45 686C145 604 203 442 203 270S147 -63 45 -147L64 -170C213 -68 275 89 275 270Z" id="g113-42"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g></svg> LY294002, <svg height="12.0395pt" id="M3" style="vertical-align:-2.3616pt" version="1.1" viewbox="-0.0498162 -9.6779 16.3096 12.0395" width="16.3096pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M300 -147C201 -63 143 98 143 270S200 602 300 686L282 710C136 610 70 450 70 271V270C70 89 136 -72 282 -170L300 -147Z" id="g113-41"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,4.688,0)"><path d="M306 382C339 403 362 417 379 433C398 450 411 473 411 500C411 578 352 635 248 635H247C181 635 134 604 106 573L56 506L82 482C117 529 151 557 201 557C246 557 287 531 287 466C287 404 228 364 143 336L150 302C165 306 186 309 204 309C258 309 324 275 324 179C324 85 285 44 235 44C175 44 128 88 106 108C92 118 80 116 69 106C56 97 39 79 39 61C39 47 46 34 63 21C83 5 123 -12 174 -12C236 -12 454 58 454 222C454 297 403 362 306 380V382Z" id="g13-49"></path><glyph.data ascent="1024" descent="-360" horiz-adv-x="500" vert-adv-y="500"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,11.462,0)"><path d="M275 270C275 450 212 609 64 710L45 686C145 604 203 442 203 270S147 -63 45 -147L64 -170C213 -68 275 89 275 270Z" id="g113-42"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g></svg> JQ1, <svg height="12.0395pt" id="M4" style="vertical-align:-2.3616pt" version="1.1" viewbox="-0.0498162 -9.6779 16.3096 12.0395" width="16.3096pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M300 -147C201 -63 143 98 143 270S200 602 300 686L282 710C136 610 70 450 70 271V270C70 89 136 -72 282 -170L300 -147Z" id="g113-41"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,4.688,0)"><path d="M486 174V231H396V629H324C229 512 123 368 15 215V174H269V116C269 55 264 41 179 34V0H477V34C403 41 396 51 396 112V174H486ZM269 231H90C155 335 219 427 267 493H269V231Z" id="g13-50"></path><glyph.data ascent="1024" descent="-360" horiz-adv-x="500" vert-adv-y="500"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,11.462,0)"><path d="M275 270C275 450 212 609 64 710L45 686C145 604 203 442 203 270S147 -63 45 -147L64 -170C213 -68 275 89 275 270Z" id="g113-42"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g></svg> I-BET 762, and <svg height="12.0395pt" id="M5" style="vertical-align:-2.3616pt" version="1.1" viewbox="-0.0498162 -9.6779 16.3096 12.0395" width="16.3096pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M300 -147C201 -63 143 98 143 270S200 602 300 686L282 710C136 610 70 450 70 271V270C70 89 136 -72 282 -170L300 -147Z" id="g113-41"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,4.688,0)"><path d="M152 515H407L439 613L433 623H115L70 303C91 310 134 322 179 322C270 322 327 264 327 174C327 100 297 45 235 45C178 45 130 84 106 106C93 117 82 120 70 112C53 99 38 76 38 61S43 36 63 20C84 2 126 -12 166 -12C226 -11 297 15 354 56C424 105 455 164 455 226C455 312 382 394 254 394C228 394 175 380 125 362L152 515Z" id="g13-51"></path><glyph.data ascent="1024" descent="-360" horiz-adv-x="500" vert-adv-y="500"></glyph.data></g><g transform="matrix(.0135,0,0,-0.0135,11.462,0)"><path d="M275 270C275 450 212 609 64 710L45 686C145 604 203 442 203 270S147 -63 45 -147L64 -170C213 -68 275 89 275 270Z" id="g113-42"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346"></glyph.data></g></svg> GSK525762 (IBET).</div>

Journal of Cancer Research

fig3

Figure 3

Figure 3: Molecular Docking Study Characterization of Rare Flavonoids at the Nac-Binding Site of the First Bromodomain of BRD4 (BRD4 BD1) 